Biogen MA sues USPTO Director for extra 23 days in term of human anti-tau antibodies patent

What is 23 days worth to you? Pharmaceutical giant Biogen MA is suing Andrei Iancu, the director of the U.S. Patent and Trademark Office, to force the PTO to extend a patent for Human Anti-Tau Antibodies for an extra 23 days because of an alleged improper calculation of delays in the approval of the patent. [...]

By | February 15th, 2018|drug patents, litigation, Patent Investing, USPTO|0 Comments

St. Regis Mohawk Tribe “is going to war” with the PTAB over concerns about its impartiality

The St. Regis Mohawk Tribe, which is trying to use its sovereign immunity to shield patents it acquired from Allergan Plc from review by the patent Trial and Appeal Board, “is going to war with the PTAB,” according to Michael Shore, a partner at Shore Chan Depumpo, who is one of the lawyers who dreamed [...]

By | January 4th, 2018|Patent Investing, PTAB, USPTO|0 Comments

Saint Regis Mohawk Tribe defends its Allergan deal in reply to opposition to dismiss IPRs

The Saint Regis Mohawk Tribe defended the controversial transaction in which Allergan Plc assigned patents for the chronic dry eye drug Restasis to the tribe for a promise to use its tribal immunity as a shield against inter partes review challenges before the Patent Trial and Appeal Board. The defense came in the form of [...]

Finjan leads all public IP licensing companies in successful defense of IPRs, Patexia says

Finjan Holdings Inc. (FNJN), the cybersecurity technology and licensing company run by CEO Phil Hartstein, leads all publicly traded patent licensing companies in defending against inter partes review challenges of its patents, according to Patexia, a global community network for intellectual property professionals. East Palo Alto, California-based Finjan has won 87% or 32 of the [...]

By | September 13th, 2017|Patent Investing, PTAB, USPTO|0 Comments

President Trump nominates Irell & Manella’s Andrei Iancu as Director of the USPTO

President Donald Trump as expected said he intends to nominate Andrei Iancu, the managing partner with the law firm of Irell & Manella LP, to be Under Secretary of Commerce for Intellectual Property and Director of the U.S. Patent and Trademark Office, Department of Commerce. Iancu has advised plaintiffs and defendants across a wide variety [...]

By | August 31st, 2017|exec changes, Patent Investing, USPTO|0 Comments

Google and other tech giants unveil the High Tech Inventors Alliance to work toward a “balanced” U.S. patent system

Adobe, Amazon, Cisco, Dell, Google, Intel, Oracle and Salesforce, who invested $62.9 billion in research and development in 2016, collectively own more than 115,000 patents and employ more than 447,000 in the U.S, have joined together to form the High Tech Inventors Alliance (HTIA), dedicated to supporting “balanced patent policy.” The alliance’s focus on a balanced patent system [...]

Crossroads seeks rehearing of ex parte re-exam at PTAB and Federal Circuit rulings cancelling patents in IPRs

Crossroads Systems (CRDS), the patent licensing company run by CEO Richard Coleman Jr., said it has asked the U.S. Patent and Trademark Office to reconsider its rejection of claims of U.S. Patent No. 7,897,311 in an ex parte reexamination proceeding. The Austin, Texas-based company said in a filing with the Securities and Exchange Commission that [...]

By | July 10th, 2017|litigation, Patent Investing, PTAB, USPTO|0 Comments

Senator Chris Coons’ STRONGER patent reform bill seen as antidote to anti-patent troll legislation

Sen. Chris Coons, a Democrat from Delaware, introduced new patent-owner friendly legislation designed to rebalance the U.S. patent system by restoring injunctive relief and getting rid of the gamesmanship in the inter partes review and post-grant review processes before the Patent Trial and Appeal Board. The new bill is called the Support Technology & Research [...]

By | June 22nd, 2017|Patent Investing, PTAB, Supreme Court, USPTO|0 Comments

U.S. Supreme Court is unlikely to find IPR process unconstitutional, patent market observers say

The U.S. Supreme Court is likely to uphold the constitutionality of the inter partes review (IPR) process in in Oil States v. Greene’s Energy Group despite what could be described as magical thinking by patent owners, patent market observers say. The high court took up only one of three questions presented by Oil States in [...]

By | June 14th, 2017|litigation, Patent Investing, PTAB, Supreme Court, USPTO|0 Comments

USPTO Associate Solicitor Matal elevated to acting director in wake of Lee’s abrupt resignation

U.S. Patent and Trademark Office Associate Solicitor Joseph Matal was elevated to perform the functions and duties of the Under Secretary of Commerce for Intellectual Property and Director of the USPTO, according to a statement by Commerce Secretary Wilbur Ross. The position is effective June 7 and follows the resignation of Michelle Lee. The statement [...]

By | June 7th, 2017|exec changes, Patent Investing, PTAB, USPTO|0 Comments